|
|
|
41
|
77249
|
AUGMENTIN 80MG/ML|11.4MG/ML SUSP (GSK) AMOXICILLIN|CLAVULANI (C)
|
AMOXICILLIN|CLAVULANIC ACID
|
AUGMENTIN
|
70ML
|
C
|
10.95
|
0.1565
|
ML
|
140
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
081216
|
PENICILLINS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
PENICILLINS
|
|
|
|
|
42
|
77249
|
AUGMENTIN 80MG/ML|11.4MG/ML SUSP (GSK) AMOXICILLIN|CLAVULANI
|
AMOXICILLIN|CLAVULANIC ACID
|
AUGMENTIN
|
70ML
|
B
|
11.77
|
0.17
|
ML
|
140
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
|
081216
|
PENICILLINS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
PENICILLINS
|
2026-02-16
|
|
|
|
40
|
7724AA
|
AUGMENTIN ES 600MG/5ML | 42.9MG/5ML SUSP (GSK/COL) AMOXICILLIN | CLAVULANIC ACID
|
AMOXICILLIN|CLAVULANIC ACID
|
AUGMENTIN ES
|
100ML
|
C
|
21.88
|
0.22
|
SUSPENSION
|
0
|
ML
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
081216
|
PENICILLINS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
7724AA
|
AUGMENTIN ES 600MG/5ML|42.9MG/5ML SUSP (GSK) AMOXICILLIN|CLA (C)
|
AMOXICILLIN|CLAVULANIC ACID
|
AUGMENTIN ES
|
100ML
|
C
|
24.06
|
0.2406
|
ML
|
0
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
081216
|
PENICILLINS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
PENICILLINS
|
|
|
|
|
42
|
7724AA
|
AUGMENTIN ES 600MG/5ML|42.9MG/5ML (C)
|
AMOXICILLIN|CLAVULANIC ACID
|
AUGMENTIN ES
|
100ML
|
C
|
26.48
|
0.26
|
ML
|
0
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
|
081216
|
PENICILLINS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
PENICILLINS
|
|
|
|
|
41
|
7724AJ
|
AMOXICILLIN|CLAVULANIC ACID 80MG/ML|11.4MG/ML SUSP (KWA) (B)
|
AMOXICILLIN|CLAVULANIC ACID
|
AMOXICILLIN|CLAVULANIC ACID
|
100ML
|
B
|
5.49
|
0.0549
|
ML
|
140
|
BOTT
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081216
|
PENICILLINS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
PENICILLINS
|
|
|
|
|
41
|
7724Q
|
CURAM 80MG/ML|11.4MG/ML SUSP (BCH) AMOXICILLIN|CLAVULANIC AC (C)
|
AMOXICILLIN|CLAVULANIC ACID
|
CURAM
|
70ML
|
C
|
28.6
|
0.4085
|
ML
|
140
|
BOTT
|
BCH
|
SANDOZ
|
COL
|
COLLINS LTD
|
|
081216
|
PENICILLINS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
PENICILLINS
|
|
|
|
|
42
|
7724Q
|
CURAM 80MG/ML|11.4MG/ML SUSP (BCH) (C)
|
AMOXICILLIN|CLAVULANIC ACID
|
CURAM
|
70ML
|
C
|
28.60
|
0.41
|
ML
|
140
|
BOTT
|
BCH
|
SANDOZ
|
COL
|
AVENTA BARBADOS
|
|
081216
|
PENICILLINS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
PENICILLINS
|
|
|
|
|
41
|
7725W
|
AMOXICILLIN|CLAVULANIC ACID 500MG|100MG INJ (RTM)
|
AMOXICILLIN|CLAVULANIC ACID
|
AMOXICILLIN|CLAVULANIC ACID
|
20ML
|
B
|
3.72
|
3.7241
|
VIAL
|
21
|
VIAL
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
081216
|
PENICILLINS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
PENICILLINS
|
|
|
|
|
40
|
77263
|
ZOSYN EDTA 4.5G INJ (PFI/STO) PIPERACILLIN/TA
|
PIPERACILLIN|TAZOBACTAM
|
ZOSYN EDTA
|
10X4.5G
|
C
|
534.01
|
53.40
|
INJECTION
|
0
|
VIAL
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
081216
|
PENICILLINS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
77263
|
ZOSYN EDTA 4G|0.5G INJ (PFI) PIPERACILLIN|TAZOBACTAM (C)
|
PIPERACILLIN|TAZOBACTAM
|
ZOSYN EDTA
|
10X4.5G
|
C
|
445.02
|
44.5017
|
VIAL
|
0
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
081216
|
PENICILLINS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
PENICILLINS
|
|
|
|
|
42
|
77263
|
ZOSYN EDTA 4G|0.5G INJ (PFI) PIPER (C)
|
PIPERACILLIN|TAZOBACTAM
|
ZOSYN EDTA
|
10X4.5G
|
C
|
549.73
|
54.97
|
VIAL
|
28
|
VIAL
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
081216
|
PENICILLINS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
PENICILLINS
|
|
|
|
|
40
|
7726AZY
|
PITAZUM 4G | 0.5G INJ (LDP/AHI) PIPERACILLIN | TA
|
PIPERACILLIN|TAZOBACTAM
|
PITAZUM
|
4.5G VIAL
|
B
|
6.09
|
6.09
|
INJECTION
|
0
|
VIAL
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081216
|
PENICILLINS
|
2022-04-01
|
2024-03-31
|
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
7726BR
|
PIPERACILLIN | TAZOBACTAM 4G | 0.5G INJ (SLS/AHI)
|
PIPERACILLIN|TAZOBACTAM
|
PIPERACILLIN|TAZOBACTAM
|
4.5G VIAL
|
B
|
7.94
|
7.94
|
INJECTION
|
0
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081216
|
PENICILLINS
|
2022-04-01
|
2024-03-31
|
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
7726BS
|
PIPERACILLIN | TAZOBACTAM 4G | 0.5G INJ (UME/AHI)
|
PIPERACILLIN|TAZOBACTAM
|
PIPERACILLIN|TAZOBACTAM
|
4.5G VIAL
|
BQ
|
4.46
|
4.46
|
INJECTION
|
0
|
VIAL
|
UME
|
UMEDICA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081216
|
PENICILLINS
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
2022-03-29
|
|
|
|
41
|
7726BW
|
AMOXICILLIN|CLAVULANIC ACID 1G|0.2G INJ (KWA) (B)
|
AMOXICILLIN|CLAVULANIC ACID
|
AMOXICILLIN|CLAVULANIC ACID
|
1.2G VIAL
|
B
|
2.94
|
2.9358
|
VIAL
|
21
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081216
|
PENICILLINS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
PENICILLINS
|
|
|
|
|
40
|
7726CF
|
LAMOXY 1G | 0.2G INJ (LDP/AHI) AMOXICILLIN | CLAV
|
AMOXICILLIN|CLAVULANIC ACID
|
LAMOXY
|
10X1.2G
|
B
|
8.15
|
0.82
|
INJECTION
|
0
|
VIAL
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081216
|
PENICILLINS
|
2022-04-01
|
2024-03-31
|
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
7726CG
|
AMOXICILLIN | CLAVULANIC ACID 1G | 0.2G INJ (RTM/
|
AMOXICILLIN|CLAVULANIC ACID
|
AMOXICILLIN|CLAVULANIC ACID
|
20ML VIAL
|
C
|
3.89
|
3.89
|
INJECTION
|
0
|
VIAL
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
081216
|
PENICILLINS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
7726CG
|
AMOXICILLIN|CLAVULANIC ACID 1G|0.2G INJ (RTM) (B)
|
AMOXICILLIN|CLAVULANIC ACID
|
AMOXICILLIN|CLAVULANIC ACID
|
20ML VIAL
|
B
|
4.21
|
4.2134
|
VIAL
|
21
|
VIAL
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
081216
|
PENICILLINS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
PENICILLINS
|
|
|
|
|
40
|
7726CK
|
AMOXICILLIN | CLAVULANIC ACID 1G | 0.2G INJ (CHC/ATB)
|
AMOXICILLIN|CLAVULANIC ACID
|
AMOXICILLIN|CLAVULANIC ACID
|
1.2G VIAL
|
B
|
3.23
|
3.23
|
INJECTION
|
0
|
VIAL
|
CHC
|
CARITAS HEALTHCARE PVT LTD
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081216
|
PENICILLINS
|
2022-04-01
|
2024-03-31
|
Price Change
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
2021-12-03
|